Literature DB >> 16116086

Enhanced NF-kappaB activation and cellular function in macrophages lacking IkappaB kinase 1 (IKK1).

Qiutang Li1, Qingxian Lu, Virginie Bottero, Gabriela Estepa, Lisa Morrison, Frank Mercurio, Inder M Verma.   

Abstract

IkappaB kinase (IKK) complex plays a key regulatory role in macrophages for NF-kappaB activation during both innate and adaptive immune responses. Because IKK1-/- mice died at birth, we differentiated functional macrophages from embryonic day 15.5 IKK1 mutant embryonic liver. The embryonic liver-derived macrophage (ELDM) showed enhanced phagocytotic clearance of bacteria, more efficient antigen-presenting capacity, elevated secretion of several key proinflammatory cytokines and chemokines, and known NFkappaB target genes. Increased NFkappaB activity in IKK1 mutant ELDM was the result of prolonged degradation of IkappaBalpha in response to infectious pathogens. The delayed restoration of IkappaBalpha in pathogen-activated IKK1-/- ELDM was a direct consequence of uncontrolled IKK2 kinase activity. We hypothesize that IKK1 plays a checkpoint role in the proper control of IkappaBalpha kinase activity in innate and adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16116086      PMCID: PMC1194954          DOI: 10.1073/pnas.0505997102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines.

Authors:  S Yoshimura; J Bondeson; B M Foxwell; F M Brennan; M Feldmann
Journal:  Int Immunol       Date:  2001-05       Impact factor: 4.823

3.  Role of NFkappaB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSI.

Authors:  S Yoshimura; J Bondeson; F M Brennan; B M Foxwell; M Feldmann
Journal:  Eur J Immunol       Date:  2001-06       Impact factor: 5.532

4.  Analysis of domains in the IKKalpha and IKKbeta proteins that regulate their kinase activity.

Authors:  Y T Kwak; J Guo; J Shen; R B Gaynor
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

5.  Zebrafish IkappaB kinase 1 negatively regulates NF-kappaB activity.

Authors:  Ricardo G Correa; Takaaki Matsui; Vinay Tergaonkar; Concepcion Rodriguez-Esteban; Juan Carlos Izpisua-Belmonte; Inder M Verma
Journal:  Curr Biol       Date:  2005-07-26       Impact factor: 10.834

6.  Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti.

Authors:  C Makris; V L Godfrey; G Krähn-Senftleben; T Takahashi; J L Roberts; T Schwarz; L Feng; R S Johnson; M Karin
Journal:  Mol Cell       Date:  2000-06       Impact factor: 17.970

7.  NEMO/IKK gamma-deficient mice model incontinentia pigmenti.

Authors:  M Schmidt-Supprian; W Bloch; G Courtois; K Addicks; A Israël; K Rajewsky; M Pasparakis
Journal:  Mol Cell       Date:  2000-06       Impact factor: 17.970

8.  IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain.

Authors:  H Sakurai; H Chiba; H Miyoshi; T Sugita; W Toriumi
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

9.  Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice.

Authors:  D Rudolph; W C Yeh; A Wakeham; B Rudolph; D Nallainathan; J Potter; A J Elia; T W Mak
Journal:  Genes Dev       Date:  2000-04-01       Impact factor: 11.361

10.  IKKalpha controls formation of the epidermis independently of NF-kappaB.

Authors:  Y Hu; V Baud; T Oga; K I Kim; K Yoshida; M Karin
Journal:  Nature       Date:  2001-04-05       Impact factor: 49.962

View more
  52 in total

Review 1.  The nuclear factor NF-kappaB pathway in inflammation.

Authors:  Toby Lawrence
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-07       Impact factor: 10.005

2.  Controlling the fate of NIK: a central stage in noncanonical NF-kappaB signaling.

Authors:  Shao-Cong Sun
Journal:  Sci Signal       Date:  2010-05-25       Impact factor: 8.192

3.  Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity.

Authors:  Eoin P Cummins; Edurne Berra; Katrina M Comerford; Amandine Ginouves; Kathleen T Fitzgerald; Fergal Seeballuck; Catherine Godson; Jens E Nielsen; Paul Moynagh; Jacques Pouyssegur; Cormac T Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

4.  Phosphorylation of SNAP-23 by IkappaB kinase 2 regulates mast cell degranulation.

Authors:  Kotaro Suzuki; Inder M Verma
Journal:  Cell       Date:  2008-08-08       Impact factor: 41.582

Review 5.  NF-κB in immunobiology.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Cell Res       Date:  2011-01-18       Impact factor: 25.617

6.  IKKα takes control of canonical NF-κB activation.

Authors:  Christiane Pelzer; Margot Thome
Journal:  Nat Immunol       Date:  2011-08-18       Impact factor: 25.606

Review 7.  Return to homeostasis: downregulation of NF-κB responses.

Authors:  Jürgen Ruland
Journal:  Nat Immunol       Date:  2011-06-19       Impact factor: 25.606

Review 8.  Cell penetrating peptide inhibitors of nuclear factor-kappa B.

Authors:  J S Orange; M J May
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

9.  I kappa B kinase alpha (IKKα) activity is required for functional maturation of dendritic cells and acquired immunity to infection.

Authors:  Alessandra Mancino; Mohamed Habbeddine; Ella Johnson; Lionel Luron; Magali Bebien; Sylvie Memet; Carol Fong; Marc Bajenoff; Xuefeng Wu; Michael Karin; Jorge Caamano; Hongbo Chi; Michael Seed; Toby Lawrence
Journal:  EMBO J       Date:  2013-02-19       Impact factor: 11.598

10.  Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis.

Authors:  Isra Darwech; Jesse Otero; Muhammad Alhawagri; Simon Dai; Yousef Abu-Amer
Journal:  J Cell Biochem       Date:  2009-12-15       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.